The microbiome industry is closer than ever to obtaining a commercial microbiome-targetting theraeutic, due to the significant amount of companies entering the clinic. This track will provide detailed analysis on the clinical progress, application of perfect trial designs, drug delivery discussions and commercial factors that should be considered now the field is advancing.

Time: 10:15 am
day: Track B - Afternoon - Day One